New Zealand at a glance
- Population
- 5.3 million 2025
- Life expectancy at birth
- 82.0 years, 2024
- People aged 65 and over
- 17.6 % of people, 2025
- Health spending per person
- 5,022 US$ per person, 2024
- Doctors
- 3.61 per 1,000 people, 2022
Updated
Reviewed by Vidhi Upadhyay
New Zealand GERD Treatment Market Industry Trends and Forecast to 2034: Segmented by (Treatment, Channel, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$37.7 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $83.1 Mn | — | — |
| 2025 (base) | $86.5 Mn | +$3.4 Mn | — |
| 2026 (forecast) | $90.0 Mn | +$3.5 Mn | +4.1% |
| 2027 (forecast) | $93.7 Mn | +$3.7 Mn | +8.4% |
| 2028 (forecast) | $97.6 Mn | +$3.8 Mn | +12.8% |
| 2029 (forecast) | $101.6 Mn | +$4.0 Mn | +17.4% |
| 2030 (forecast) | $105.7 Mn | +$4.2 Mn | +22.3% |
| 2031 (forecast) | $110.1 Mn | +$4.3 Mn | +27.3% |
| 2032 (forecast) | $114.6 Mn | +$4.5 Mn | +32.5% |
| 2033 (forecast) | $119.3 Mn | +$4.7 Mn | +37.9% |
| 2034 (forecast) | $124.2 Mn | +$4.9 Mn | +43.6% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $86.5 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $124.2 Mn placeholder estimate |
| Growth (CAGR), 2025–2034 | 4.1% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Treatment, channel and end user (see all) |
| Key players | Takeda Pharmaceutical Company Ltd, AstraZeneca, Phathom Pharmaceuticals, Haleon PLC, Bayer AG (see all) |
| Regulator in New Zealand | MedsafeSource: Medsafe. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
GERD treatments relieve acid reflux and heartburn with acid-lowering medicines and procedures.
Key segments of the GERD Treatment market include treatment (Proton Pump Inhibitors, P-CABs and H2 Blockers) and channel (Prescription and Over-the-Counter).
Rising rates of gut and liver disease linked to diet, obesity and alcohol, more screening and new treatments are driving the GERD Treatment market.
Microbiome-based treatments, earlier testing and digital gut-health programmes give the GERD Treatment market room to grow.
Late diagnosis, stigma, limited specialist access and high prices of new medicines hold back the GERD Treatment market.
The GERD Treatment market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Medsafe, part of the Ministry of Health, approves medicines before they can be sold.[1] Pharmac decides which medicines and medical devices the public health system pays for.[2]
Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for GERD Treatment. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in New Zealand.
What doctors and scientists are doing in GERD Treatment right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 19 Nov 2026.
[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 19 Nov 2026.
[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 19 Nov 2026.
From our blog
New Zealand · 2 shared keywords
New Zealand · 2 shared keywords
New Zealand · 1 shared keyword
New Zealand
New Zealand
New Zealand
OTC & Nutraceuticals · New Zealand
Medical Devices · New Zealand
OTC & Nutraceuticals · New Zealand
Medical Devices · New Zealand
OTC & Nutraceuticals · New Zealand
Medical Devices · New Zealand